Combined blood markers correctly detect early pancreatic cancer in human cancer cells
A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research from the Perelman School of Medicine at University of Pennsylvania. Currently over 53,000 people in the United States are diagnosed with pancreatic cancer — the fourth leading cause of cancer death — every year. The blood biomarkers, detailed today in Science Translational Medicine, correctly detected pancreatic cancer in blood samples from patients at different stages of their disease.
The majority of pancreatic cancer patients are not diagnosed until an advanced stage, beyond the point at which their tumors can be surgically removed.
A team led by Ken Zaret, PhD, director of the Penn Institute for Regenerative Medicine and the Joseph Leidy Professor of Cell and Developmental Biology, and Gloria Petersen, PhD, from the Mayo Clinic, identified a pair of biomarkers that physicians could soon use to discover the disease earlier.
“Starting with our cell model that mimics human pancreatic cancer progression, we identified released proteins, then tested and validated a subset of these proteins as potential plasma biomarkers of this cancer,” Zaret said. The authors anticipate that health care providers will use the early-detection biomarkers to test for their presence and levels in blood from pancreatic cancer patients and blood drawn from individuals with a high risk of developing pancreatic cancer, including those who have a first-degree relative with pancreatic cancer, are genetically predisposed to the disease, or who had a sudden onset of diabetes after the age of 50.
“Early detection of cancer has had a critical influence on lessening the impact of many types of cancer, including breast, colon, and cervical cancer. A long standing concern has been that patients with pancreatic cancer are often not diagnosed until it is too late for the best chance at effective treatment,” said Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center (ACC) at the University of Pennsylvania. “Having a biomarker test for this disease could dramatically alter the outlook for these patients.”
Novel method for discovering pancreatic cancer biomarkers
Credit: The lab of Ken Zaret, Perelman School of Medicine, University of Pennsylvania
The biomarker panel, enabled by discovery work of first author Jungsun Kim, PhD, a postdoctoral fellow in Zaret’s lab, builds on a first-of-its-kind human-cell model of pancreatic cancer progression the lab described in 2013. They used stem-cell technology to create a cell line from a patient with advanced pancreatic ductal adenocarcinoma. Genetically reprogramming late-stage human cancer cells to a stem-cell state enabled them to force the reprogrammed cells to progress to an early cancerous state, revealing secreted blood biomarkers of early-stage disease along the way.
The best candidate biomarker, plasma thrombospondin-2 (THBS2), was screened against 746 cancer and control plasma samples using an inexpensive, commercially available protein-detection assay. The team found that blood levels of THBS2, combined with levels of a known later-stage biomarker called CA19-9, was reliable at detecting the presence of pancreatic cancer in patients.
The team refined the assay with independent investigations of plasma samples from patients with different stages of cancer, from individuals with benign pancreatic disease, and from healthy controls, all obtained from Petersen, who directs the biospecimen resource program for pancreas research at the Mayo Clinic.
“Positive results for THBS2 or CA19-9 concentrations in the blood consistently and correctly identified all stages of the cancer,” Zaret said. “Notably, THBS2 concentrations combined with CA19-9 identified early stages better than any other known method.” The combination panel also improved the ability to distinguish cases of cancer from pancreatitis. The panel will next be validated in a set of samples from pancreatic cancer patients who provided a research blood sample prior to their diagnosis.
The Latest on: Pancreatic cancer
- Pancreatic Cancer Survivor Nick Pifani Believes Genetic Testing Helped Him Beat the Oddson November 21, 2019 at 9:59 am
November 21 marks World Pancreatic Cancer Day, a reminder that the disease that took the lives of Steve Jobs and Patrick Swayze — and is currently being battled by Jeopardy! host Alex Trebek — still ...
- Wear purple for World Pancreatic Cancer Day Thursdayon November 21, 2019 at 9:18 am
Thursday is World Pancreatic Cancer Day, a day to bring awareness to the form of cancer expected to take the lives of more than 45,000 in the U.S. people this year alone. People are encouraged to wear ...
- Arc of Dreams joins Eiffel Tower, other world monuments in pancreatic cancer awareness eventon November 21, 2019 at 8:56 am
Arc of Dreams joins Eiffel Tower, other world monuments in pancreatic cancer awareness event Pancreatic cancer is the third leading cause of cancer death nationwide. Check out this story on ...
- Nov. 21 is World Pancreatic Cancer Dayon November 21, 2019 at 8:42 am
Hodgkin’s lymphoma and testicular cancer awareness violet ribbon symbolic bow color on white background (isolated with clipping path) TAMPA (WFLA) — November 21 is World Pancreatic Cancer Day, a day ...
- Skilli World Trivia App Pledges to Donate Up to $100k to National Pancreatic Cancer Foundation in Honor of Trivia Legend Alex Trebekon November 21, 2019 at 8:03 am
UNTIL DECEMBER 15th SKILLI WORLD WILL DONATE $5 FOR EVERY PLAYER THAT REGISTERS WITH THE PROMO CODE '4ALEX' AND MAKES A DEPOSIT ON THE APP November is Pancreatic Cancer Awareness Month and in light of ...
- Pancreatic cancer tumor classification could optimize treatment choiceson November 21, 2019 at 7:44 am
A study from the University of North Carolina Lineberger Comprehensive Cancer Center could help predict resistance to treatments for pancreatic cancer, one of the deadliest cancer types. In Clinical ...
- World Pancreatic Cancer Day: Send us pictures of your loved oneson November 20, 2019 at 10:18 am
(WXYZ) — Pancreatic cancer is considered the world's toughest cancer. It has the lowest survival rate of all major cancers. But people who are committed to fighting this disease are wearing their ...
- World Pancreatic Cancer Day 2019on November 20, 2019 at 6:41 am
Join Jupiter Medical Center and Jeopardy! host, Alex Trebek as they come together with millions of others to raise awareness for Pancreatic Cancer research on World Pancreatic Cancer Day.For More ...
- Pancreatic cancer survivor from Berks offers hope to others diagnosed with the diseaseon November 19, 2019 at 2:22 pm
From there he went to a gastroenterologist, who gave him a startling diagnosis. The Ruscombmanor Township man had pancreatic cancer, the third-leading cause of death from cancer in the United States, ...
- Chemotherapy impacts on the cellular response to CDK4/6 inhibition: distinct mechanisms of interaction and efficacy in models of pancreatic canceron November 19, 2019 at 12:08 pm
Gastroenterology. 2016;150:48–63. Hidalgo M, Cascinu S, Kleeff J, Labianca R, Lohr JM, Neoptolemos J, et al. Addressing the challenges of pancreatic cancer: future directions for improving outcomes.
via Google News and Bing News